Cells · 2021 · 17 citations · 52 references
MedicineMolecular BiologyOncologyChemotherapyMolecular OncologyTranscriptional RegulationApoptosis ResistanceCancer Cell SignalingCancer ProgressionGrowth Factor SignalingSignal Transduction In CancerActive Chromatin LocalizationProtein Binding In OncologyViral Integration Into Host GenomeViral Integration Sites
Patients with prostate cancer (PCa) receiving docetaxel chemotherapy invariably develop chemoresistance. The transcription co-activator lens epithelium-derived growth factor p75 (LEDGF/p75), also known as DFS70 and PSIP1, is upregulated in several human cancers, including PCa and promotes resistance to docetaxel and other drugs. The C-terminal region of LEDGF/p75 contains an integrase binding domain (IBD) that tethers nuclear proteins, including the HIV-1 integrase and transcription factors, to active chromatin to promote viral integration and transcription of cellular survival genes. Here, we investigated the contribution of the LEDGF/p75 IBD interactome to PCa chemoresistance. Quantitative immunoblotting revealed that LEDGF/p75 and its IBD-interacting partners are endogenously upregulated in docetaxel-resistant PCa cell lines compared to docetaxel-sensitive parental cells. Using specific human autoantibodies, we co-immunoprecipitated LEDGF/p75 with its endogenous IBD-interacting partners JPO2, menin, MLL, IWS1, ASK1, and PogZ, as well as transcription factors c-MYC and HRP2, in docetaxel-resistant cells, and confirmed their nuclear co-localization by confocal microscopy. Depletion of LEDGF/p75 and selected interacting partners robustly decreased the survival, clonogenicity, and tumorsphere formation capacity of docetaxel-resistant cells. These results implicate the LEDGF/p75 IBD interactome in PCa chemoresistance and could lead to novel therapeutic strategies targeting this protein complex for the treatment of docetaxel-resistant tumors.
52
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2021 · 17.4K citations · Full text
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic, Dorothy Ngo-Yin Fan, Dimitri Belenki et al. · Nature · 2017 · 1.1K citations
Medicine, Cancer Biology, Oncology +12
Peter C. Scacheri, Orit Rozenblatt–Rosen, Natasha J. Caplen et al. · Proceedings of the National Academy of Sciences · 2004 · 609 citations · Full text
Targeting the MLL complex in castration-resistant prostate cancer
Rohit Malik, Amjad Khan, Irfan A. Asangani et al. · Nature Medicine · 2015 · 216 citations · Full text